Clinical trial
Role of Omega-3 Fatty Acids in Modulating Retinal Microvascular Changes in Type 1 Diabetes
NCT07255326 is registered in ClinicalTrials.gov with University of Faisalabad as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Omega-3 Fatty Acids in Modulating Retinal Microvascular Changes in Type 1 Diabetes
- Lead sponsor
- University of Faisalabad
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 12, 2025
- Completion date
- February 1, 2026
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic retinopathy, omega 3 fatty acids, type 1 diabetes